MRI-LINAC: A transformative technology in radiation oncology
Frontiers in Oncology · 27.01.2023 · 13
DOI: 10.3389/fonc.2023.1117874 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 27.01.2023. Verfasst von John Ng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, United States. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Advances in radiotherapy technologies have enabled more precise target guidance, improved treatment verification, and greater control and versatility in radiation delivery. Amongst the recent novel technologies, Magnetic Resonance Imaging (MRI) guided radiotherapy (MRgRT) may hold the greatest potential to improve the therapeutic gains of image-guided delivery of radiation dose. The ability of the MRI linear accelerator (LINAC) to image tumors and organs with on-table MRI, to manage organ motion and dose delivery in real-time, and to adapt the radiotherapy plan on the day of treatment while the patient is on the table are major advances relative to current conventional radiation treatments. These advanced techniques demand efficient coordination and communication between members of the treatment team. MRgRT could fundamentally transform the radiotherapy delivery process within radiation oncology centers through the reorganization of the patient and treatment team workflow process. However, the MRgRT technology currently is limited by accessibility due to the cost of capital investment and the time and personnel allocation needed for each fractional treatment and the unclear clinical benefit compared to conventional radiotherapy platforms. As the technology evolves and becomes more widely available, we present the case that MRgRT has the potential to become a widely utilized treatment platform and transform the radiation oncology treatment process just as earlier disruptive radiation therapy technologies have done.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, United States.
- Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti, Bari, Italy.
Zitieren
APA
Ng, J., Gregucci, F., Pennell, R. T., Nagar, H., Golden, E. B., Knisely, J. P. S., Sanfilippo, N. J., & Formenti, S. C. (2023). MRI-LINAC: A transformative technology in radiation oncology. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1117874
Vancouver
Ng J, Gregucci F, Pennell RT, Nagar H, Golden EB, Knisely JPS, et al. MRI-LINAC: A transformative technology in radiation oncology. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1117874
BibTeX
@article{Ng2023,
author = {Ng, John and Gregucci, Fabiana and Pennell, Ryan T and Nagar, Himanshu and Golden, Encouse B and Knisely, Jonathan P S and Sanfilippo, Nicholas J and Formenti, Silvia C},
title = {MRI-LINAC: A transformative technology in radiation oncology},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1117874}
}
EUVIMED